# Xponential Fitness, Inc.: financial statements, quarterly

XPOF · NYSE · CIK 1802156 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/xpof.md) · [Financials](/companies/xpof/financials.md) · [Filings](/companies/xpof/filings.md) · [Insiders](/companies/xpof/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/xpof/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [80.4](/filings/0000950170-24-124333.md) | [89.5 d](/filings/0001802156-26-000016.md) | [79.7](/filings/0000950170-25-068272.md) | [76.9](/filings/0000950170-25-105975.md) | [80.5](/filings/0001193125-25-272807.md) | [83.2 d](/filings/0001802156-26-000016.md) | [76.9](/filings/0001802156-26-000065.md) | [76.2](/filings/0001802156-26-000095.md) | [78.8](/filings/0001193125-25-272807.md) | [83.0 d](/filings/0001802156-26-000016.md) | [60.7](/filings/0001802156-26-000065.md) | [66.0](/filings/0001802156-26-000095.md) |
| Selling, general and administrative | $m | [43.9](/filings/0000950170-24-124333.md) | [52.9 d](/filings/0001802156-26-000016.md) | [36.6](/filings/0000950170-25-068272.md) | [37.0](/filings/0000950170-25-105975.md) | [46.2](/filings/0001193125-25-272807.md) | [57.1 d](/filings/0001802156-26-000016.md) | [45.5](/filings/0001802156-26-000065.md) | [24.1](/filings/0001802156-26-000095.md) | [24.7](/filings/0001193125-25-272807.md) | [57.7 d](/filings/0001802156-26-000016.md) | [30.0](/filings/0001802156-26-000065.md) | [32.0](/filings/0001802156-26-000095.md) |
| Operating income | $m | [7.5](/filings/0000950170-24-124333.md) | [(1.8) d](/filings/0001802156-26-000016.md) | [8.0](/filings/0000950170-25-068272.md) | [(3.1)](/filings/0000950170-25-105975.md) | [(6.6)](/filings/0001193125-25-272807.md) | [(51.9) d](/filings/0001802156-26-000016.md) | [9.7](/filings/0001802156-26-000065.md) | [14.8](/filings/0001802156-26-000095.md) | [3.6](/filings/0001193125-25-272807.md) | [(8.2) d](/filings/0001802156-26-000016.md) | [13.0](/filings/0001802156-26-000065.md) | [9.5](/filings/0001802156-26-000095.md) |
| Interest expense | $m | [10.6](/filings/0000950170-24-124333.md) | [11.5 d](/filings/0001802156-26-000016.md) | [11.5](/filings/0000950170-25-068272.md) | [11.3](/filings/0000950170-25-105975.md) | [11.8](/filings/0001193125-25-272807.md) | [11.6 d](/filings/0001802156-26-000016.md) | [11.4](/filings/0001802156-26-000065.md) | [13.0](/filings/0001802156-26-000095.md) | [12.9](/filings/0001193125-25-272807.md) | [11.9 d](/filings/0001802156-26-000016.md) | [14.5](/filings/0001802156-26-000065.md) | [14.9](/filings/0001802156-26-000095.md) |
| Income tax | $m | [0.2](/filings/0000950170-24-124333.md) | [0.8 d](/filings/0001802156-26-000016.md) | [(0.0)](/filings/0000950170-25-068272.md) | [0.1](/filings/0000950170-25-105975.md) | [0.1](/filings/0001193125-25-272807.md) | [(0.6) d](/filings/0001802156-26-000016.md) | [0.5](/filings/0001802156-26-000065.md) | [0.3](/filings/0001802156-26-000095.md) | [0.3](/filings/0001193125-25-272807.md) | [0.3 d](/filings/0001802156-26-000016.md) | [0.0](/filings/0001802156-26-000065.md) | [0.1](/filings/0001802156-26-000095.md) |
| Net income | $m | [(3.4)](/filings/0000950170-24-124333.md) | [(9.0) d](/filings/0001802156-26-000016.md) | [(2.5)](/filings/0000950170-25-068272.md) | [(9.6)](/filings/0000950170-25-105975.md) | [(12.1)](/filings/0001193125-25-272807.md) | [(43.5) d](/filings/0001802156-26-000016.md) | [(1.9)](/filings/0001802156-26-000065.md) | [1.0](/filings/0001802156-26-000095.md) | [(4.9)](/filings/0001193125-25-272807.md) | [(32.9) d](/filings/0001802156-26-000016.md) | [(0.7)](/filings/0001802156-26-000065.md) | [(4.1)](/filings/0001802156-26-000095.md) |
| Diluted EPS | $ per share | [(0.50)](/filings/0000950170-24-124333.md) | not reported | [(0.29)](/filings/0000950170-25-068272.md) | [(0.30)](/filings/0000950170-25-105975.md) | [(0.29)](/filings/0001193125-25-272807.md) | not reported | [(0.10)](/filings/0001802156-26-000065.md) | [(0.01)](/filings/0001802156-26-000095.md) | [(0.18)](/filings/0001193125-25-272807.md) | not reported | [(0.02)](/filings/0001802156-26-000065.md) | [(0.10)](/filings/0001802156-26-000095.md) |
| Basic EPS | $ per share | [0.91](/filings/0000950170-24-124333.md) | not reported | [(0.29)](/filings/0000950170-25-068272.md) | [(0.30)](/filings/0000950170-25-105975.md) | [(0.29)](/filings/0001193125-25-272807.md) | not reported | [(0.10)](/filings/0001802156-26-000065.md) | [(0.01)](/filings/0001802156-26-000095.md) | [(0.18)](/filings/0001193125-25-272807.md) | not reported | [(0.02)](/filings/0001802156-26-000065.md) | [(0.10)](/filings/0001802156-26-000095.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Current assets | $m | [117](/filings/0000950170-23-060612.md) | [97.0](/filings/0000950170-25-039541.md) | [87.8](/filings/0000950170-24-053165.md) | [85.7](/filings/0000950170-24-090222.md) | [95.6](/filings/0000950170-24-124333.md) | [84.1](/filings/0001802156-26-000016.md) | [100](/filings/0000950170-25-068272.md) | [103](/filings/0000950170-25-105975.md) | [99.2](/filings/0001193125-25-272807.md) | [94.6](/filings/0001802156-26-000095.md) | [75.0](/filings/0001802156-26-000065.md) | [69.4](/filings/0001802156-26-000095.md) |
| Total assets | $m | [551](/filings/0000950170-23-060612.md) | [530](/filings/0000950170-25-039541.md) | [508](/filings/0000950170-24-053165.md) | [475](/filings/0000950170-24-090222.md) | [472](/filings/0000950170-24-124333.md) | [403](/filings/0001802156-26-000016.md) | [412](/filings/0000950170-25-068272.md) | [400](/filings/0000950170-25-105975.md) | [355](/filings/0001193125-25-272807.md) | [346](/filings/0001802156-26-000095.md) | [322](/filings/0001802156-26-000065.md) | [310](/filings/0001802156-26-000095.md) |
| Current liabilities | $m | [102](/filings/0000950170-23-060612.md) | [102](/filings/0000950170-25-039541.md) | [92.4](/filings/0000950170-24-053165.md) | [91.8](/filings/0000950170-24-090222.md) | [94.1](/filings/0000950170-24-124333.md) | [108](/filings/0001802156-26-000016.md) | [123](/filings/0000950170-25-068272.md) | [113](/filings/0000950170-25-105975.md) | [93.2](/filings/0001193125-25-272807.md) | [116](/filings/0001802156-26-000095.md) | [99.0](/filings/0001802156-26-000065.md) | [93.0](/filings/0001802156-26-000095.md) |
| Total liabilities | $m | [628](/filings/0000950170-23-060612.md) | [624](/filings/0000950170-25-039541.md) | [600](/filings/0000950170-24-053165.md) | [576](/filings/0000950170-24-090222.md) | [596](/filings/0000950170-24-124333.md) | [597](/filings/0001802156-26-000016.md) | [609](/filings/0000950170-25-068272.md) | [596](/filings/0000950170-25-105975.md) | [559](/filings/0001193125-25-272807.md) | [718](/filings/0001802156-26-000095.md) | [694](/filings/0001802156-26-000065.md) | [686](/filings/0001802156-26-000095.md) |
| Long-term debt | $m | [319](/filings/0000950170-23-060612.md) | [319](/filings/0000950170-25-039541.md) | [319](/filings/0000950170-24-053165.md) | [318](/filings/0000950170-24-090222.md) | [342](/filings/0000950170-24-124333.md) | [342](/filings/0001802156-26-000016.md) | [352](/filings/0000950170-25-068272.md) | [353](/filings/0000950170-25-105975.md) | [349](/filings/0001193125-25-272807.md) | [501](/filings/0001802156-26-000095.md) | [500](/filings/0001802156-26-000065.md) | [500](/filings/0001802156-26-000095.md) |
| Current portion of debt | $m | [5.2](/filings/0000950170-23-060612.md) | [4.8](/filings/0000950170-25-039541.md) | [5.1](/filings/0000950170-24-053165.md) | [5.1](/filings/0000950170-24-090222.md) | [5.4](/filings/0000950170-24-124333.md) | [5.4](/filings/0001802156-26-000016.md) | [5.5](/filings/0000950170-25-068272.md) | [5.5](/filings/0000950170-25-105975.md) | [10.1](/filings/0001193125-25-272807.md) | [5.3](/filings/0001802156-26-000095.md) | [5.3](/filings/0001802156-26-000065.md) | [5.3](/filings/0001802156-26-000095.md) |
| Shareholders' equity | $m | [(138)](/filings/0000950170-23-060612.md) | [(130)](/filings/0000950170-25-039541.md) | [(144)](/filings/0000950170-24-053165.md) | [(152)](/filings/0000950170-24-090222.md) | [(156)](/filings/0000950170-24-124333.md) | [(217)](/filings/0001802156-26-000016.md) | [(225)](/filings/0000950170-25-068272.md) | [(225)](/filings/0000950170-25-105975.md) | [(230)](/filings/0001193125-25-272807.md) | [(269)](/filings/0001802156-26-000095.md) | [(316)](/filings/0001802156-26-000065.md) | [(321)](/filings/0001802156-26-000095.md) |

- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.6 d](/filings/0000950170-24-124333.md) | [(5.5) d](/filings/0001802156-26-000016.md) | [2.7](/filings/0000950170-25-068272.md) | [3.0 d](/filings/0000950170-25-105975.md) | [5.2 d](/filings/0001193125-25-272807.md) | [0.8 d](/filings/0001802156-26-000016.md) | [5.8](/filings/0001802156-26-000065.md) | [2.5 d](/filings/0001802156-26-000095.md) | [9.3 d](/filings/0001193125-25-272807.md) | [10.7 d](/filings/0001802156-26-000016.md) | [(21.7)](/filings/0001802156-26-000065.md) | [(4.0) d](/filings/0001802156-26-000095.md) |
| Capital expenditure | $m | [1.8 d](/filings/0000950170-24-124333.md) | [1.3 d](/filings/0001802156-26-000016.md) | [0.9](/filings/0000950170-25-068272.md) | [2.1 d](/filings/0000950170-25-105975.md) | [1.8 d](/filings/0001193125-25-272807.md) | [(0.1) d](/filings/0001802156-26-000016.md) | [0.5](/filings/0001802156-26-000065.md) | [1.5 d](/filings/0001802156-26-000095.md) | [1.1 d](/filings/0001193125-25-272807.md) | [0.5 d](/filings/0001802156-26-000016.md) | [0.5](/filings/0001802156-26-000065.md) | [0.3 d](/filings/0001802156-26-000095.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001802156-26-000016.md) | not reported | not reported | not reported | [0.0 d](/filings/0001802156-26-000016.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [26.2](/filings/0000950170-23-060612.md) | [30.8](/filings/0000950170-24-053165.md) | [41.6](/filings/0000950170-24-090222.md) | [40.2](/filings/0000950170-24-124333.md) | [31.1](/filings/0000950170-25-068272.md) | [31.8](/filings/0000950170-25-105975.md) | [32.2](/filings/0001193125-25-272807.md) | [33.9](/filings/0001802156-26-000065.md) | [35.0](/filings/0001802156-26-000095.md) | [35.1](/filings/0001193125-25-272807.md) | [37.3](/filings/0001802156-26-000065.md) | [42.0](/filings/0001802156-26-000095.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.